May 18 (Reuters) – Tiny Israeli drugmaker Oramed
Pharmaceuticals Inc on Wednesday said its experimental
oral insulin succeeded in significantly reducing night-time
blood glucose in patients with type…
The post Oramed says oral insulin succeeds in midstage type 2 diabetes trial appeared first on NASDAQ.